Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: One thing that needs to be clarified

Over 75 global companies from the US, Europe, Japan, Korea and Taiwan have licensed the MMP Portfolio™ technologies (from the Alliacense website re; Tyco)

In a pacer previously posted by Wolf, I believe it stated over 90 have licensed the MMP

Just today Redbird reported a response from PTSC investor relations as follows:

There are over 90 MMP licensees to date.

Is there some reason why Alliacense isn't on board with saying over 90? Sure clouds things up for anyone and everyone who wants to know the real number.

Share
New Message
Please login to post a reply